S&P Futures
5,761.75 +23.25 (+0.41%) Dow Futures
42,120.00 +173.00 (+0.41%) Nasdaq Futures
20,091.50 +69.75 (+0.35%) Russell 2000 Futures
2,224.90 +16.30 (+0.74%) Crude Oil
71.12 +1.86 (+2.69%) Gold
2,769.90 +20.60 (+0.75%)
Autolus Therapeutics plc (AUTL)
Pre-Market:
| Previous Close | 4.0000 |
| Open | 4.0000 |
| Bid | 2.8800 x 200 |
| Ask | 4.3100 x 200 |
| Day's Range | 3.3300 - 4.0000 |
| 52 Week Range | 3.0600 - 7.4500 |
| Volume | |
| Avg. Volume | 930,421 |
| Market Cap | 896.737M |
| Beta (5Y Monthly) | 2.03 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.1400 |
| Earnings Date | Nov 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.40 |
GlobeNewswireAutolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
LONDON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its third quarter 2024 financial results and operational highlights before open of US markets on Tuesday, November 12, 2024. Management will host a conference call and webcast at 8:30 am EDT/1:30 pm BST to discuss the company’s financial results and provide a general business upda
Insider MonkeyAutolus Therapeutics (AUTL): High-Growth UK Stock in Cancer Therapy
We recently published a list of 8 High Growth UK Stocks to Invest In. In this article, we are going to take a look at where Autolus Therapeutics (NASDAQ:AUTL) stands against other high growth UK stocks to invest in. According to a KPMG report, the United Kingdom’s GDP growth is projected to slow in the […]
